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Abstract: 
Chlamydia trachomatis infections are the most common bacterial cause of sexually 
transmitted disease in the world. In women, these infections often result in such 
serious reproductive tract complications as pelvic inflamatory disease, infertility, and 
ectopic pregnancy and an infected woman can pass the infection to her newborn 
during delivery. The diagnosis of C Trachomatis infections has historically been 
difficult, but newer chlamydia diagnostic tests have become clinically available in the 
past decade.  
  
Key Words:  
Chlamydia trachomatis, Infectıon, Cell culture, Pelvic inflammatory disease, Ligase 
chain reaction, Polymerase chain reaction, Epidemiology. 
 
 
 
 
 
© Uluslararası İnsan Bilimleri Dergisi ISSN: 1303-5134  
www.InsanBilimleri.com  
 
 
 
2
 
Introduction 
Chlamydia trachomatis infections are the most common bacterial cause of sexually 
transmitted disease (STD) in the world (1). In women, these infections often result in 
serious reproductive tract complication, such as pelvic inflamotory disease (PID), 
infertility, and ectopic pregnancy (2). In addition, an infected pregnant women can pass 
the infection to her newborn during delivery, resulting in such problems as ophtalmia 
neonatorum,which appears as conjunctivitis 5 to 12 days after birth. C trachomatis is 
also a common cause of subacute, afebrile pneumonia in newborn (3,10). 
A large number of published studies have examined the prevalence and characteristics 
of chlamydial infections, mostly among sexually active women attending clinics for 
family planning, prenatal care, the diagnosis and treatment of STD (4,12). Regardless 
of the region of the country or the population density, the prevalence and risk factor are 
similar.The highest prevalence has been reported among sexually active adolescent 
females 17 years of age and younger in USA (4,17,18,19). More than 105 of sexually 
active young women tested in various clinics have been found to have chlamydial 
infections, a level significantly high enough that routinely testing for chlamydia 
suggested (5,6,7). 
A high number of sexual partner and concurrent gonorrhea infection are commonly 
associated with chlamydial infection. In fact , patients with gonococcal infection are so 
commonly coinfected with C trachomatis that treatment advised if no diagnostic test for 
chlamydia will be performed(7,8). While there is no consistent evidence that oral 
contraceptives raise the risk of chlamydial infection, the data clearly indicate that 
barrier contraception protects against chlamydial infection (8,13). 
Approximately 70% of chlamydial infections and 50% of gonococcal infections in 
women are asyptomatic. Asymptomatic carriage of chlamydia in men as well as in 
women may be prolonged,often persisting for months. Little is known about the 
efficiency of sexual transmission chlamydia , but it appears that chlamydia is more 
difficult to transmit than gonorrhea(9). In addition, chlamydial infections may facilitate 
human immunodeficiency virus transmission(10). 
  
Clinical signs 
Women if not adequately treated, develop pelvic inflammatory disease (PID). Scarring 
sequelae of PID will cause involuntary infertility in 20%, ectopic pregnancy in 9%, and 
chronic pelvic pain in 18% of women (11). 
The endocervix is the most common site infected by C. trachomatis in women; 
however, the urethra and rectum may also be infected. Most cervical chlamydial 
infections do not cause sufficient inflamation to result in clinical signs (11,12). When 
symptoms do occur, they most commonly include vaginal discharge and /or 
dysuria(12). The presence of green or yellow mucopus on swab from within the 
cervical os or 10 or more polymorphonuclear leukocytes (PMNs) Per oil immersion 
field of Gram’s stained cervical secretions is strongly associated with chlamydial 
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infection and termed “mucopurulent cervicitis”, the female equivalent of urethritis in 
men (13,22).Some experts reserve the diagnosis of mucoprulent cervicitis for finding of 
30 or more PMNs per high-power field on a cervical Gram’s stain(13,14) . The 
ascension of lower genitourinary tract infection to the endometrium and fallopian tubes 
may cause lower abdominal pain and menstrual abnormalities. The proportion of with 
chlamydial infection who develop infection of the upper reproductive tract (including 
endometritis,salpingitis,and pelvic peritonitis) is unknown(14,15). 
Pelvic inflammatory disease. The rate at which chlamydial organisms have been 
recovered from patients with symptoms of PID has varied widely, probably, because of 
differences in the populations being studied and in the methods used to recover the 
organisms. Investigators from Europe and North America have found a higher 
proportion of C trachomatis than Neisseria gonorrhoeae in women with 
microorganisms in 5 % to 51 % of women in the US treated for PID (7,15,16,17). 
The clinical presentation of symptomatic chlamydial PID is essentially the same as that 
caused by other organisms, although it appears that symptoms may be milder than 
those caused by gonococcal PID. The major presenting complaint is lower abdominal 
pain that is usually constant but may be intermittent. Increased vaginal discharge or 
fever may or may not be present. Symptoms commonly begin at the time of 
menstruation (18).  
The role of asymptomatic or subclinic chlamydial PID in the development of 
reproductive problems has assumed greater importance. Colonization of the fallopian 
tube by C trachomatis has been found in infertile women who have no clinical 
symptoms of PID and no laparoscopic signs of active pelvic infection. Ectopic 
pregnancy may result from prior chlamydial tubal damage(19).  
Neonatal complication. Infection of neonates with C trachomatis results from perinatal 
exposure to the mother’s infected cervix. The prevalence of C trachomatis infection 
generally exceeds 5% among pregnant women, regardless of race/ethnicity or 
socioeconomic status. İnitial C trachomatis perinatal infection involves mucous 
membranes of the eye, oropharynx, urogenital tract, and rectum. Chlamydia is the 
most frequent identifiable cause of ophthalmia neonatorum and should be considered 
the probable etiology for conjunctivitis in all infants who develop conjonctivitis within 
the first 30 days of life (10,20). 
C trachomatis is also a common cause of subacute, afebrile pneumonia with onset 
from 1 to 3 months of age. Cough with tachypnea, and hyperinflation and bilateral 
diffuse infiltrates on a chest roentgenogram is characteristic. Wheezing are are 
rare,and children are typically afebrile. Because variation from this clinical presentation 
is common, initial treatment and diagnostic tests should encompass C trachomatis for 
all infants 1 to 3 months of age who have possible pneumonia (4,21). 
  
© Uluslararası İnsan Bilimleri Dergisi ISSN: 1303-5134  
www.InsanBilimleri.com  
 
 
 
4
Laboratory diagnosis 
Because chlamydiae are obligate intracellular organisms that infect columnar 
epitelium, the objective of good specimen collection should be to obtain columnar 
epithelial cells from the endocervix or uretra. The diagnosis of chlamydial STDs 
generally has been difficult and remains a challenge, but never chlamydia diagnostic 
tests have been clinically available in the past decade (11,14,22,23). Tissue culture 
remains the gold standart , yet its application in clinical settings ranging from university 
hospital to local family medicine office and public health clinics is limited by a lack of 
appropiate reference laboratories , technical expertise, funds or recognition of 
chlamydiae as important STD pahogens. The requirement of at least 3 to 7 days for 
optimal chlamydial growth diminishes cell culture clinical utility. Once the specimen is 
collected, it must be kept refrigerated for no longer than 24 hours before inoculation 
onto prested McCoy cells . The preferred method for detection of chlamydia in tissue 
culture is with a florescein- labeled antibody that is specific for C trachomatis and 
reacts with the inclusion body formed inside the cell. Since tissue culture amplifies 
small numbers of organisms are expected (19, 23). Antigen Detection.  New 
nonculture diagnostic tests, each with their own utility and limitations, were introduced 
in the 1980s. The direct fluorescent antibody (DFA) test is based on detection of 
elementary bodies (EB) in patient specimens using a fluorescein - labeled monoclonal 
antibody that is specific for either the major outer membrane protein of C trachomatis 
or the lipopolysaccharide (LPS) moiety of the EB. A distinct advantage of DFA is that 
the quality of the specimen can be assesssed. Since it is applied to a slide, the direct 
visualization of epithelial cells in the specimen under fluorescent microscopy indicates 
an adequate specimen was obtained. Slides can be restored at 4°C for a few months 
or at -80°C indefinetely. The sensitivity, specificity, an positif predictive values for DFA 
have been assessed by comparison with culture. In high prevalence populations 
(>5%), sensitivity varies from 70% to 90% depending on the quality of the specimen 
collected, patients characteristics including age and STD risk factors , the tecnical 
reliability of the laboratory performing cultures. The specificity is from 96 %to 99 % in 
the same high prevalence populations (21,24,25). False negative and false positif 
results can occur but are more of a problem in low prevalence groups (<5%).  
The enzyme immunoassay test (EIA) employs polyclonal or monoclonal antibodies that 
detect chlamydial LPS . The antibodies are conjugated with an enzyme that reacts with 
a substrate to produce a colored product if chlamydiae are present. A 
spectrophotometer is required to detect the intensity of the colored product. A major 
disadvantage of this assay is that the antibodies with the LPS of other bacterial species 
found in the vagina or urinary tract and may produce a fale positive result. This is also 
not species specific for C trachomatis. Most EIA tests contain a blocking antibody that 
can be used to confirm a positive test. The sensitivities, specificities, and positive 
predictive values for EIA are similar to those for DFA(14,25,26). Nucleic acid 
hybridization. Nucleic acid hybridization (probe) tests chemiluminescent type DNA 
probe that is complementary to a sequence of ribosomal RNA in the chlamydial 
genome of the patient sample. A distinct advantage of this assay is that it is specific for 
C trachomatis and does not cross react with other bacteria. Specimen can be stored at 
room temperature in special transport material and processed within 7 days. The 
sensitivity and specificity rates are similar to those for DFA, and EIA. The availability of 
nucleic acid amplification technologies may make non invasive urine testing avilable for 
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young men and for young women when a gynecologic examination is not otherwise 
required. Accurate detection of asymptomatic chlamydial disease in a timely,cost 
effective,and noninvasive manner as well as development of effective partner 
treatment strategies remain important challenges. This review provides a clinical 
update on office based testing for C Trachomatis, management and treatment options 
for the adolescent and young adult population (8,26). 
Two additional nucleic acid type assays recently were developed: ligase chain reaction 
(LCR) and polymerase chain reaction (PCR). With these tests, detection is achived by 
exponential amplification of a specific DNA target sequence. Studies suggested that 
LCR and PCR in urine both men and women are more sensitive than culture; 
sensitivities for the nucleic acid tests reach 95% compared with 85% for cultures. A 
major problem,however,is the interpretation of positive tests in asymptomatic 
individuals in low prevelance populations; in this situation,the assay may represent 
residual DNA but non viable organisms(14,27). Leukocytes estrase screening. The 
leukocyte esterase test (LET) detects enzymes that are released by 
polymorphonuclear white blood cells. LET only confirms a diagnosis of urethritis; it fails 
to determine the specific causative agent of urethral inflammation.The test comes in 
the form of a dipstick on which a purple color is produced whrn indoxyl carbonate ester 
is hydrolyzed by leukocyte esterases. At present, LET is only recommended as a 
screening test for urethritis in adolescent boys. Because further studies are required to 
assess its usefulness,LET is not recommended for use in older men or in women as a 
chlamydia screening test (1,4,11,14,25,28). Serology Two serologic tests 
microimmunnofluorescence and complement fixation are available for use. Both 
require a high level of technical expertise,and have a little value in the rutine clinical 
care of patients with possible chlamydial genital infections (2,7,24,28,29). 
  
Conclusion 
The prevalence and financial impact of C trachomatis infection in Türkiye necessitate 
that family physician and gynecologist continue their survillance for this 
disease,especially in women,where the sequelae of untreated chlamydial infection are 
significant.  
To reduce the morbidity and subsequent complications associated with Chlamydia 
trachomatis infection in Türkiye, effective control and prevention strategies must be 
implemented. Selective screening to detect asymptomatic infection is an essential 
component of all control programs. Without effective screening programs, women will 
continue to become infertile and to seek expensive surgery; ectopic pregnancies will 
occur and endanger mother’s life; and newborns will be at increased risk for exposure 
and greater chance of developing pneumonia and eye infection. 
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